Skip to main content
Home
User account menu
  • Log in
Main navigation
  • About Us
  • Research
    • Current Studies
    • Research Areas
      • Hematologic Malignancy
      • Human Papillomavirus
      • Kaposi's Sarcoma
      • Solid Tumor
      • Laboratory Resources Committee
    • Sites
      • Africa
      • Latin America
      • USA
    • Scholar Award
  • Outreach
  • Resources
    • Educational Materials
    • Press Releases
    • Publications
    • Media
    • Related Websites
  • Meeting Logistics
    • **DRAFT** 2025 AMC LATAM Regional Investigators’ Meeting
      • Summary
      • Tentative Agenda
      • Hotel/Meeting Venue
      • Travel
      • Reimbursement
      • Webcast Participation
      • Registration
  • Contact Us
Slider 1

The AIDS Malignancy Consortium (AMC)

National Cancer Institute-supported clinical trials group founded in 1995 to support innovative trials for AIDS-related cancers.

Slider2

Our Mission

Investigate new treatment and prevention interventions for malignancies in people living with HIV and to study the pathobiology of these tumors in the context of clinical trials.

A Global Consortium

world map image

The AMC is composed of 36 Clinical Trials Sites worldwide, five Working Groups, an Administrative Office, a Statistical Office, and an Operations and Data Management Office.
 

EXPLORE

 

clinical icon

Research

Current Studies:

  • Current Studies

Sites:

  • Africa
  • Latin America
  • USA

Outreach and Community

Patient Outcomes, Survivorship, and Engagement Committee (POSEC)

AMC Resources

Educational Materials

Press Releases

Publications

Media

Related Websites

This Project has been funded in whole or in part with Federal funds from the NIH/NCI under Grant #UM1CA121947

Copyright ©, The Emmes Company, LLC